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A B S T R A C T
Sixty years ago the clinical neurophysiology of epilepsy had progressed to the stage that it posed
questions that could be addressed bymajor advances in cellular electrophysiologymade around the that
time. However, it took about 25–30 years to build up serious momentum in understanding the
mechanisms of epileptic discharges. Over the past 2–3 decades developments in pharmacology and
molecular biology have substantially increased the depth and complexity of our insights into the nervous
system in general and the epileptic brain in particular. One of the biggest advances in our understanding
of the brain is in its plasticity in the adult – that is its ability to modify its structure and function. The
current state of play is that for most chronic epileptic foci it is possible to identify multiple differences
from normal brain tissue in both the structure and function of neurons, neuronal networks and glia. This
review will chart some of this progress to give an idea of the pace of advances over the decades.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Seizure
journal homepage: www.e lsev ier .com/ locate /yse izEpilepsy is a condition inwhich neurons and neuronal networks
malfunction to cause the sometimes dramatic symptoms of
seizures. People, and other animals, without epilepsy can
experience ‘‘symptomatic’’ seizures – the structure and function
of the brain carries the risk of generating seizures if they are
exposed to convulsant drugs or conditions. The epileptic brain
generates seizures without any such trigger: this means that it has
differences in structure and/or function that make it susceptible to
spontaneous seizures, and that can also lead to altered behaviour
and/or cognition between seizures, as reﬂected in the relatively
recent concept of ‘‘Epilepsy Spectrum Disorder’’.
Seizures are essentially amalfunctioning of the brain, due to the
‘‘misﬁring’’ of its neurons, somuch of this reviewwill centre on the
essentially electrophysiological processes involved in generating
seizures and other abnormal EEG activity. I will outline some
aspects of clinical electrophysiology and of experimental
approaches before considering how improvements in our under-
standing of the fundamentals of the nervous system over the past
60 years have impacted on epilepsy research. Space constraints, as
well as my personal expertise, have led me to concentrate mainly
on focal epilepsies.
1. Clinical electrophysiology of epilepsy
A great deal has happened in clinical neuroscience over the past
60 years. The electroencephalogram or EEG had been discovered
much earlier, with Berger publishing his pivotal paper in 1929.1 TheE-mail address: J.G.R.Jefferys@bham.ac.uk.
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doi:10.1016/j.seizure.2010.10.026EEG was becoming more routine during the late 1940s and early
1950s, especially in epilepsy diagnosis.2,3 In one discussion paper
Walter2 outlined the use of the EEG in epilepsy in ways that are still
relevant today (Fig. 1A). The key point from this work was that
epileptic seizures were associated with abnormally synchronous
brain activity, essentially a foundation for much of what follows.
Arguably the biggest breakthrough in clinical neurophysiology
over the past 60 years was the advent of digital recording and the
increasing power and availability of computers. For decades the
mechanical constraints of the chart recorder limited bandwidth, or
the range of signal frequencies, of the EEG to something under
100 Hz (Fig. 1B shows relevant components of the EEG spectrum,
from4 Ref. 4. Digital EEG recordings became available in the early
1990s, and in most cases simply emulated paper-based recordings
but with less mess and bulk. However, two key papers did exploit
the wider bandwidth to show that high-frequency activity (over
100 Hz) was associated with epileptic seizures.5,6 Towards the end
of 1990s even faster recordings demonstrated the presence of
‘‘ripples’’ (80–200 Hz) and ‘‘fast ripples’’ (>200 Hz), and particu-
larly implicated fast ripples as markers for the epileptogenic
zone.4,7 Fast rippleswere associatedwith epilepsy-related losses of
neurons known as hippocampal sclerosis, both clinically and in
experimental models8 (Fig. 1D), though our own recent evidence
argues that this lesion is not necessary for fast ripples,9 suggesting
that some more subtle pathophysiology is operating.
High frequency activity is best recorded with microwires
inserted into the tissue of the epileptic focus, most likely because
the synchronous activity that generates each cycle of the
oscillations covers a limited volume of brain tissue.4,10 Most
epilepsy centres still use macro-electrodes with recording surfacesvier Ltd. All rights reserved.
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Fig. 1. Recordings of epileptic activity from 1951 to 2010. (A) Classical EEG recording of bilateral spike and wave discharges published in 1951. Note the slight curvature of
some parts of the recording, which is due to the arc followed by the pens as they responded to the voltage. (B) The spectrum covered by the EEG. Chart recorders were limited
to a few tens of Hz (the Berger Bands in the ﬁgure), perhaps reaching as fast as 100 Hz as the technology improved. (C) Interictal fast ripple recorded from a microelectrode
implanted in the seizure onset zone of themedial temporal lobe of an epileptic patient. Top panel is the raw recording, middle is the signal band-pass ﬁltered 80–1000 Hz and
the bottom panel is a spectrogram with frequency on the y-axis and time (0–300 ms) on the x-axis, and higher power is indicated by hot colours (pale in monochrome).
(D) Interictal discharge and fast ripples recorded from the hippocampus of an epileptic rat, with the raw recording (i), fast ripples isolated from early and late in the interictal
discharge (ii, iii) and the corresponding spectrogram with areas of high power labelled (iv). The fast recordings and signal processing required for panels C and D are only
possible with the advent of faster recording systems and modern computers. Panel A is from Walter et al.,2 by permission of the Royal Society of Medicine Press, London.
Panels B and C are taken from Worrell et al.4 Panel D is from Jiruska et al.9 Panels B–D by permission of the authors, Oxford University Press and the Guarantors of Brain.
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surface of the brain. These can record high-frequency activity
reliably up to around 100 Hz and can detect some activity up to
200 Hz, while the much smaller microwires, tens of microns in
diameter, can record epilepsy-related high-frequency activity over
500 Hz.4 Two-dimensional high-density arrays of microelectrodes
recently produced new surprises, revealing highly localized
(hundreds of microns) areas of hypersynchronous activity, which
have been termed ‘‘microseizures’’11 (Fig. 2). Along with the
spatially restricted high-frequency interictal activity, these high
resolution recordings reveal that the pathophysiology of the
epileptic focus operates in volumes of cortex 1 mm2, which
would contain neuronal populations of a few tens of thousands.
2. Experimental models of epilepsy
Experimental models of epilepsy go back much longer than 60
years. The freeze lesion was ﬁrst reported by Openchowski12 and
intracerebral tetanus toxin by Roux and Borrel.13 A substantial
monograph has reviewed the range of experimental models ofepilepsy recently,14 but I will outline some of the major historic
phases. The real growth in experimental epilepsy started with the
use of strychnine in 1950s, and then a range of convulsants during
1960s including Metrazol, picrotoxin and penicillin. Depending on
the way penicillin was administered it was possible to use it as a
model of both focal and generalized epilepsies.15 The 1950s also
saw the use of metals and metal compounds to induce epileptic
foci, including alumina (aluminium oxide) and cobalt, but interest
has since moved on to other agents. Injection of iron salts into the
brain (initially during 1980s) also establishes chronic epileptic foci,
and can be considered as modelling iron salts left after the
breakdown of red blood cells that had bled into brain tissue
following head injury.
Genetic models of epilepsy go back to before 1950, when
epileptic traits were identiﬁed in inbred strains of rats and mice.
Selective breeding of both rats and mice, in particular for absence
and tonic clonic seizures, grew from the late 1970s and is reviewed
elsewhere.14,16 The physiological phenotypes and the speciﬁc
genes responsible for those epileptic traits are being unravelled at
an increasing pace, particularly over the last 10–15 years.17
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Fig. 2.Microseizures recorded in human brain using microelectrodes in subdural grid. (A) Novel subdural grids with microelectrodes (electrode surface areas 103 mm2), as
well as conventional macroelectrodes (10 mm2), produced new insights into activity in the epileptic brain. (B) Microseizure appears on a single microelectrode
demonstrating its tight localization (pink/grey background). (C) Enlargement of microseizure. From Stead et al. (2010) ‘‘Microseizures and the spatiotemporal scales of
human partial epilepsy’’, Brain 133(9):2789–97 by permission of the authors, Oxford University Press and the Guarantors of Brain.
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an artiﬁcial cerebrospinal ﬂuid played a pivotal role in experimen-
tal work on epilepsy. They had been used for biochemical studies
of metabolism back in 1930s, but their advantages for epilepsy
research18 and particularly for cellular electrophysiology19 became
clear from the mid-1960s to early 1970s, when convulsant drugs,
or changes in extracellular ions, were found to produce recogni-
sably epileptic activity, in most cases resembling interictal
discharges.20 The brain slice preparation provided many of the
advantages of the invertebrate and peripheral preparations, which
were exploited in many of the critical early advances in
fundamental neuroscience outlined below, but did so with
mammalian brain tissue making it more directly relevant to
epilepsy.During the late 1960s the ‘‘kindling’’ model was identiﬁed21:
electrical stimulation of certain brain regions, when repeated daily,
leads to a progressive and permanent reduction in seizure
threshold and increase in strength of seizure response. While it
is hard to induce spontaneous seizures through kindling, it has
been a very useful model of chronic epileptic foci, and of the
process known as ‘‘epileptogenesis’’ that converts normal into
epileptic brain tissue. Having models of chronic epilepsy is
important when the goal is to treat epilepsy rather than
symptomatic seizures in normal brain. One example of this is in
the development of levetiracetam (Keppra), which failed in the
standard anticonvulsant drug screening models in normal rodents
but proved very effective in the chronic kindling model in
rodents.22
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were developed during the late 1970s and early 1980s. The tetanus
toxin model,23,24 which we continue to use in my laboratory,9,25 is
characterised by a latent period of a week or two during which the
neuronal circuits undergo epileptogenesis which leads to sponta-
neous seizures. In this model neuronal loss is minimal, except in a
minority of cases which develop hippocampal sclerosis after the
onset of spontaneous recurrent seizures. Several other chronic
models rely on an initial very prolonged period of seizures known
as ‘‘status epilepticus’’, which can be induced by one of: kainic
acid,26 pilocarpine27 or prolonged electrical stimulation.28 In all
these cases epileptogenesis occurs during a latent period of aweek
or two, before spontaneous seizures start. The big difference in
these models is the substantial neuronal loss caused by status
epilepticus at the outset. Other models attempt to simulate
clinical risk factors more directly, both acquired,29 and inherited.
However, genetic background is proving a major factor in
ﬁnding epilepsy phenotypes in transgenic models of epilepsy-
related mutations.16
The concept of the latent period in acquired, chronic models of
epilepsy is fundamentally important. It models the clinical concept
that acquired epilepsies usually occur many months or years after
some kind of precipitating injury. Finding ways of treating the
process of epileptogenesis, that links the initial injury to the
development of seizures, is a major priority, as noted by an NIH
Workshop in 2002.30 Most antiepileptic drugs have minimal
impact on epileptogenesis, so other classes of drugs are being
tested.31
3. Fundamental neuroscience: advances in techniques
Our understanding of the fundamentals of the operation of the
nervous system was at a critical stage 60 years ago. The ﬁeld stood
at the start of a rapid growth in insights into the functional
properties of both individual neurons and the synapses through
which they communicate. This progress went through a series of
stages, reﬂecting advances in the technology available. Between
the late 1940s and the mid-1990s electrophysiology was the
technique that drove much of the progress. Improvements in
electronics led to better ampliﬁers and to the control circuitry
required for voltage clamp.32 This recordingmethod uses feedback
electronics to clamp the membrane potential at a speciﬁc voltage,
and measures the electric current needed to do so; these injected
currents are equal and opposite to the currents ﬂowing through ion
channels in the membrane. Under normal conditions the voltage-
dependent ion channels that are responsible for the special
properties of neurons have permeabilities (or electric conduc-
tance) that depend both on voltage (obviously) and on time.
Voltage clamp circuitry holds the membrane of the neuron at a set
voltage to reveal the time dependence of the ion channels, while
step changes of the controlled voltage reveals the voltage
dependence. This technical advance led directly to the revolution
in our understanding of the action potential developed by Hodgkin
and Huxley at the start of this 60-year review period, a topic I will
return to below.
The intracellular ‘‘sharp’’ glass microelectrode (ﬁlled with salt
solution to provide electrical continuity between the inside of the
cell and the recording apparatus) was ﬁrst used to investigate
synaptic transmission in work published in 1951.33 This technical
developmentmade it possible to recordmembrane potentials from
relatively small cellular components and has been a mainstay of
cellular electrophysiology since then. Three decades later the
‘‘single-electrode voltage clamp’’ extended the voltage clamp
method to cells that were too small to accommodate the two
separate electrodes required for the original voltage clamp
methods, by the trick of switching a single microelectrode rapidlybetween the two functions of recording voltage and injecting
current to control that voltage.34 The original intracellular glass
microelectrode was made as sharp as possible, with a sub-micron
tip in some cases, to make it possible to poke the tip through the
cell membrane into the intracellular spacewithout doing toomuch
damage. The next major advance in cellular electrophysiology was
made in 1970s and early 1980s with the advent of the patch
clamp.35 These larger (1 mm tip diameter) glass pipettes were
deliberately made smooth so that they could attach to the outside
of the cell membrane, sticking so ﬁrmly that the leak resistance
could be measured in giga-ohms. The relatively large diameter of
the electrode provided low-resistance, low-noise recordings of the
signal at the tip of the electrodes. Various tricks allowed recordings
from inside cells (‘‘whole-cell’’) or from the inside or outside of
patches of membrane.35
Parallel advances in chemical and molecular sciences contrib-
uted to our growing understanding over the past 60 years. More
speciﬁc drugs and toxins led to a deeper understanding of the
diversity of both voltage-gated ion channels and synaptic receptors
based on pharmacology. This approach had a long history with the
classical distinction of the muscarinic and nicotinic classes of
acetylcholine receptor in the autonomic nervous system, but when
chemists started synthesizing derivatives of putative neurotrans-
mitters the diversity of receptorsmade a considerable step change,
for instance with the amino acids.36 More recently molecular
biology has impacted on neuroscience along with the other life
sciences, perhaps starting with the cloning of nicotinic cholinergic
receptors of the neuromuscular junction in the early 1980s,37 an
approach that rapidly expanded into other classes of channel and
receptor and had a major impact on the classiﬁcation of voltage
dependent ion channels and synaptic receptors.38,39
Advances in imaging and molecular biology have led to the
development of new methods to study and manipulate neurons,
synapses and neuronal networks. Immunohistochemistry and in
situ binding histochemistry have revolutionised our ability to
localize speciﬁc proteins and RNA within neurons and other cells,
allowing detection of molecular changes with subcellular preci-
sion, and of losses of speciﬁc classes of neuron in epileptic tissues
(respectively starting starting late 1970s/early 1980s and 1990s).
Confocal microscopy has greatly improved the resolution of
microscopy of both ﬁxed and living tissue (from 1990s). Progress
inmicroscopy of the brainmade a big step forward as a result of the
discovery of green ﬂuorescent protein and related compounds in
luminescent jelly ﬁsh in 1960s and 1970s; now a huge range of
these ﬂuorescent proteins exists and can be used to label cells
selectively, a great help in a tissue as complex as the brain. The new
science of optogenetics (developed over the last 4–5 years) uses
other specialised proteins, initially isolated from bacteria, which,
when introduced into neuronal membranes, allows the use of light
to control the excitability and activity of selected classes of
neurons both in vivo and in vitro.40 Non-invasive imaging, ﬁrst
computer tomography using X-rays and then Magnetic Resonance
Imaging and fMRI became important clinical tools (respectively
from 1970s to 1980s), and can be useful in experiments on chronic
epilepsy models.
4. Intrinsic properties: voltage-gated ion channels
It was clear that neurons communicated through action
potentials along their axons, and that those action potentials
were electrical events (as suggested by the name) that depended
on the movements of ions, particularly sodium and potassium,
across the neuronal cell membrane. Technical advances, particu-
larly in voltage clamp recordings, culminated in 1952 in the
publication of four pivotal papers by Hodgkin, Huxley and Katz,
back to back, in the Journal of Physiology, which deﬁned in exquisite
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the squid.32,41–43 The precision of the quantitative analysis in these
papers is remarkable; the use of mathematical methods and
modelling, in conjunction with physiological measurement,
anticipating the relatively recent growth in what has come to be
called ‘‘systems biology’’ by many decades.
Advances in molecular biology have shown us in considerable
detail the structure of ion channels, revealing an even greater
complexity than could have been imagined 60 years ago. During
1980s ion channels started to be sequenced, with the electric eel’s
sodium channel published in 1984.44 We now know of 9
molecularly distinct voltage gated sodium channels, four of which
occur in the brain.45 The genes for two of these channels have
substantial numbers of mutations that have been linked to
epilepsy: SCN1A has 700 and SCN2A 20.45 (Epilepsy genetics
is considered inmore detail byM Rees elsewhere in this issue.) The
sodium channel differs from many other voltage gated ion
channels in that the pore that allows the ions to cross the
membrane comprises a single large protein (thea subunit) instead
of an assembly of several smaller subunits. It resembles some other
ion channels in having an accessory protein, the b subunit, which
plays a role in getting the sodium channels to the correct location
on the neuronal surface also and controls the activity of the a
subunit, especially the inactivation that follows each action
potential.
The b subunit also has mutations that are linked with epilepsy,
and was one of the ﬁrst ‘‘epilepsy genes’’ identiﬁed, in 1998.46 The
GEFS+ (generalized epilepsy with febrile seizures+) was a new
syndrome which describes families rather than individuals, and is
based on successive generations having a variety of kinds of
epilepsy, often including febrile seizures. This seems to represent a
fundamental change in classifying epilepsy, away from diagnosing
the speciﬁc epilepsy of the individual patient and towards
identifying a genetic mutation shared by family members, but
resulting in different clinical symptoms. This is one of the major
changes over the past 60 years, and perhaps reﬂects our growing,
although still modest, understanding of the causes of epilepsies.
Sodium channels can have abnormal epilepsy-related proper-
ties without mutations in their genes. Several acquired clinical and
experimental epilepsies47–49 have slower inactivation and weak-
ened responses to antiepileptic drugs that normally target sodium
channels, such as carbamazepine (sodium channels were identi-
ﬁed as a target for certain AEDs 1980).50
Voltage-gated calcium channels had long been known to be
critical in cardiac function, and had been implicated in synaptic
transmission, but were ﬁrst studied in neurons in depth during
1970s.51 Electrophysiology allowed the classiﬁcation of calcium
channels into low- and high-voltage activated, and together with
pharmacology into 5 distinct types (L, P/Q, N, R, T); molecular
biology revealed ten a (pore forming) subunits and four b
subunits. The IUPHAR database on ion channels provides a
comprehensive list of both voltage- and ligand-gated ion channels
and gives some idea of the massive expansion of the numbers of
ion channels identiﬁed in cell membranes (http://www.iuphar-
db.org/DATABASE/).
The diversity of known voltage-gated potassium channels grew
substantially in parallel to that for sodium and calcium, with over
40 distinct subunits on the IUPHAR database, and many more
potassium channels in other classes including the Two-P, inwardly
rectifying and calcium-activated. Mutations of some potassium
channel genes are associated with epilepsy, for instance KCNQ2
and KCNQ3 (the ‘‘M-current’’) with benign familial neonatal
seizures.52 Other potassium channels change in chronic epileptic
foci, for instance IA which is down-regulated in experimental
epileptic foci, allowing action potentials to invade further up
dendrites.53One ﬁnal voltage-gated ion channel should be mentioned, Ih,
which is an inward (depolarizing) current thatwas identiﬁed in the
heart during 1970s but now is of growing interest in the brain.54 It
is altered in several experimental models of epilepsy and has an
impact on neuronal excitability.55,56
5. Synaptic transmission
The term synapse was coined at the end of the 19th century by
Sherrington. At the start of 1950s Fatt and Katz discovered the
‘‘quantal’’ mechanism of synaptic transmission at the neuromus-
cular junction,33 laying the groundwork for the idea that
transmitters are packaged into vesicles. Evidence for inhibitory
synapses in the mammalian spinal cord ﬁrst appeared in 1955,57
but it was not clear at that stage that glycine was the transmitter.
Evidence for speciﬁc chemical neurotransmitters ﬁrst appeared
during 1920s and 1930s with the identiﬁcation of acetylcholine
and noradrenaline as neurotransmitters by Loewi, Dale, Feldberg
and others. In 1950 acetylcholine was probably the only well-
documented transmitter in the brain. The ﬁrst papers on roles for
noradrenaline and serotonin in the brain appeared in 1960s,58,59
reﬂecting technical developments in recording from single
neurons in the brain and in focal application of chemicals by
microiontophoresis from micropipettes.
Evidence on the most common neurotransmitters in the brain,
glutamate and GABA, did not start to accumulate until 1970s,
following their identiﬁcation in crustaceans during 1960s. Their
effects on CNS neurons had been established in 1960.36 The
difﬁculty was demonstrating that the actions of the applied
chemicals matched that of the endogenous neurotransmitter,
which had towait for the synthesis of agonist and antagonist drugs
which really took off in 1970s.60
Now it is clear that there a large number of different
neurotransmitters, including: acetylcholine, amino acids (gluta-
mate, aspartate, GABA, glycine), monoamines (noradrenaline,
dopamine, histamine, serotonin), purines such as adenosine, and
an ever growing list of dozens of neuropeptides. Most of these
neurotransmitters have multiple classes of receptor (as shown in
the IUPHAR database). Acetylcholine receptors have been men-
tioned already: nicotinic receptors are ligand-gated ion channels,
or ionotropic receptors, while muscarinic are metabotropic or G-
protein coupled receptors, and so have slower electrophysiological
actions because they depend on biochemical reactions to produce
second messengers which open or close physically separate ion
channels. The amino acids and some other classes of neurotrans-
mitters also have both ionotropic and metabotropic receptors. The
synthesis of selective agonists and antagonists let to subclassiﬁca-
tions, in the case of ionotropic glutamate receptors into AMPA,
kainate and NMDA. Molecular approaches further divided this
classiﬁcation into 18 different subunits that coassemble into
complete glutamate receptors.38 Ionotropic GABAA receptor
subunits have a similar diversity.61
Two aspects of progress in neurotransmitters are particularly
signiﬁcant for epilepsy. The recognition of GABA as the major
inhibitory transmitter of the brain led to attempts to synthesize
GABA-enhancing drugs.50 Benzodiazepine was known to be
anticonvulsant before its effects on GABA receptors were identi-
ﬁed. Gabapentin was developed as a drug acting at the GABAA
receptor but turned out to act at a calcium channel subunit, and
interestingly may be more effective in treating epileptogenesis
than in preventing seizures in established epilepsy. Other GABA-
targeted drugs include tiagabine, which slows GABA uptake and
prolongs its synaptic action, and vigabatrin, which blocks the
enzyme that degrades intracellular GABA. Both have some value as
anticonvulsants, although vigabatrin can have serious complica-
tions on vision that need careful monitoring. The second aspect
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Fig. 3. Intracellular and whole cell recordings of epileptic activity. (A) One of the
earliest published recordings of the PDS with superimposed brief action potentials
recorded intracellularly from the cat neocortex in vivo following application of
penicillin. The corresponding ﬁeld potential (or depth EEG recording) is
superimposed and a 100 Hz sinusoid provides a timescale. Voltage calibrations
are 1 mV for the cortical surface recording (the smooth curve) and 10 mV for the
intracellular recording. Recording was photographed from an oscilloscope screen,
which can record much faster activity than a chart recorder, but remains an
analogue method. (B) Whole cell recordings from a pair of hippocampal neurons in
vitro in a slice exposed to 0 Mg2+ and 8.5 mM K+. Pyramidal neurons are large and
have extensive dendrites as shown by the cell labelled with biocytin during
recording (i). Modern recording methods cope with the very fast depolarizations of
action potentials during PDSs (ii p1), and allow the second pyramidal neuron to be
voltage clamped to 0 mV to hide excitatory synaptic currents and to reveal
inhibitory synaptic currents, which are prominent during the PDS in this model.
These inhibitory synaptic currents were blocked by the GABAA receptor antagonist,
gabazine (iii), conﬁrming that they were IPSCs. Panel A is from Matsumoto and
Ajmone-Marsan,67 with permission, Elsevier Press. Panel B is from Marchionni and
Maccaferri80 with permission of the authors, John Wiley and Sons and The
Physiological Society.
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antagonists proved to be very effective anticonvulsants in animal
models but proved to have undesirable cognitive side effects in
humans (similar side effects occur in rodents but are hard to
detect). One NMDA receptor antagonist, ketamine, has been used
in treating the prolonged seizures of status epilepticus.50 Drugs
with selective actions on speciﬁc NMDA receptor subunits (e.g.
felbamate) exist, and research continues on drugs that modulate
the function of NMDA and other glutamate receptors.50
Space prevents inclusion of many other aspects of the basic
mechanisms of epilepsies, but I will brieﬂy mention two other
issues. First, the extracellular environment is rather changeable,
especially during hyperactivity, and it is clear that transient
increases in extracellular potassium ions, and changes in other
ions, and extracellular currents produced by neuronal activity, can
all play roles in epileptic activity.62 Second, evidence is accumu-
lating that glia may play active roles in brain function and in
epilepsy: their role in potassium homeostasis has been known
since 1970s, in transmitter re-uptake since the mid 1970s, and in
releasing glutamate and other ‘‘gliotransmitters’’ onto neurons
since the mid 1990s.63
6. Circuits
The analysis of neuronal circuits starts in earnest with the
classical work of Ramon y Cajal in the late 19th century and
Sherrington in the early 20th. Eccles started to publish on the
problem of relating cellular electrophysiology with the EEG in
1951, at the start of the review period,64 progressing into
dissecting the neuronal circuits of speciﬁc brain regions during
1960s.65 Similar methods were soon applied to the pathophysiol-
ogy of epileptic discharges, usually induced by convulsants such as
penicillin.66–69 An early outcome from this work was the discovery
of the Paroxysmal Depolarization Shift (PDS; Fig. 3),67 which is an
abrupt, all-or-none depolarization which occurred during inter-
ictal discharges lasting a few hundred milliseconds (or tenths of
seconds). Two alternative hypotheses emerged, that could broadly
be categorized as the epileptic neuron versus the epileptic
network. In practice it really is impossible to divorce the two:
epilepsy is essentially a collective phenomenon that requires
synchrony amongst large numbers of neurons, but the reason for
the excessive synchrony and excitation can be abnormal intrinsic
properties (the epileptic neuron), or abnormal circuitry (the
epileptic network), or (in most cases?) both.
The epileptic neuron concept developedwith the discovery that
individual neurons could producewaveforms similar to the PDS, as
a result of relatively slow voltage-dependent ion currents, such as
calcium70 or sodium currents that are much slower than typical
action potentials.71 While the PDS clearly had some properties of
voltage-gated ion channels, it also had properties suggesting it was
a giant excitatory postsynaptic potential (EPSP).72–74 In practice it
is impossible to produce a large EPSP without activating voltage-
dependent inward (depolarizing) currents mediated by sodium
and/or calcium ions, if those ion channels are present; in turn these
relatively slow depolarizations can drive bursts of fast action
potentials and thus amplify the synaptic outputs from each
neuron.75 The idea that the PDS is due to positive feedback through
a synaptic network goes back to the early 1970s.72 It took a
combination of realistic computer simulations and experimental
electrophysiology, mostly in brain slices in vitro, to demonstrate
the importance in generating epileptic activity of both the intrinsic
properties of individual neurons and the synaptic networks that
connect them.76–78 Essentially, recurrent collaterals between the
pyramidal cells of the hippocampus allowed a ‘‘chain reaction’’ of
excitation which recruited the whole population into the epileptic
discharge. Even small networks of neurons have extremelycomplex properties with many interdependent processes operat-
ing in parallel; simulating them quantitatively in synaptically
connected model neurons provides a valuable tool to dissect the
roles of speciﬁc ion channels or synaptic receptors, and most
importantly to make experimentally testable predictions to
determine whether the theoretical model is plausible.20 An
important result from this work was that epileptic discharges
needed a critical mass, or size of neuronal population, to sustain
epileptic activity: a few thousand pyramidal cells in the case of
interictal discharges in vitro. The clinical equivalent may be the
microseizures which are generated by a few tens of thousands of
neurons.11
The networks responsible for epileptic activity have proved
more a good deal more complex than the ﬁrst cellular studies of
epileptic activity suggested, for instance with the active participa-
tion of inhibitory interneurons in driving epileptic bursts.79,80
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experimental chronic epileptic foci can also be usefully studied
in vitro, or rather ex vivo. While the in vitro preparation
generally does not lend itself to the long range connections that
participate in epileptic seizures in vivo, it does preserve the
neurons and local circuits of the focus and can provide
substantial insights into the cellular and synaptic mechanisms
associated with the epileptogenic tissue. These studies have
revealed complex changes in epileptic foci, which depend on the
speciﬁc cell type and brain (sub-)region, and can include altered
voltage-gated ion channels (see above), synaptic transmission,
connectivity, selective neuronal losses and so on (reviewed in20
Ref. 20). The multiplicity of changes found in most chronic
epileptic foci will represent a complex mix of pro- and anti-
epileptic mechanisms, and no doubt some epiphenomena, which
are likely to progress over time, partly in response to repeated
epileptic seizures.
7. Plasticity
Over the past few years it has become increasingly clear that the
mature mammalian brain is a good deal more plastic, or
modiﬁable, than was thought 60 years ago. The sprouting of
new axons and synaptic connections in response to lesions in the
mammalian forebrain was discovered in the late 1970s81 and in
response to epileptic activity in the late 1980s.82 In these cases
axons grow into territories that they do not normally innervate and
create aberrant synaptic networks which may well play a role in
epileptic foci. The production of new neurons in the mature
mammalian brain, or ‘‘adult neurogenesis’’ was also considered
impossible 60 years ago, and still meets resistance from some
quarters. However there is good evidence for progenitor cells
surviving in the subgranular zone of the hippocampal dentate
gyrus and in the subventricular zone. The process of neurogenesis
is complex, with multiple stages and fates for the cells, but at least
some of them become new neurons. The rate of neurogenesis
increases with epileptic activity, although the functional implica-
tions remain far from clear.83
The primary generalized epilepsy that is understood in some
detail in terms of its basic mechanisms is absence. It differs from
the focal epilepsies in the requirement for dynamic interaction
between the thalamus and neocortex to produce the classic 3 per
second (in humans) spike and wave discharge which is synchro-
nized across most of the cortex. Conceptual models of the
distributed circuits required to generate absence seizures have
evolved over the 60 years covered by this review and are outlined
in84 Ref. 84. In short back in 1954 the idea was that a pacemaker in
the thalamus projected diffusely to the cortex and thus produced
the rhythmic spike and wave discharge, the ‘‘centrencephalic’’
theory. In the early 1990s the cellular mechanisms of the thalamic
pacemaker were being resolved in detail. However the cortex is a
necessary partner in absence epilepsy, and other teams postulated
(in 1968) that it was an abnormal cortex which turned normal
thalamic oscillations into absence seizures, the ‘‘corticoreticular’’
theory. This received support from an ingenious in vitro experi-
ment in which thalamic slices were connected to an electronically
simulated neocortex: changing the properties of the ‘‘neocortex’’
induced absence-like activity on the thalamus.85 More recently
(from 2002) several lines of evidence, both physiological and
pharmacological,84,86 lead to the theory that absence seizures are
initiated by a cortical focus (perhaps complicating the idea that
absence is a primary generalized epilepsy). The general idea is that
the cortical focus drives the thalamus which produces a
widespread drive to the cortex and that the two structures then
both are necessary for sustaining the rhythmic discharge for the
rest of the seizure.848. Conclusions
Sixty years ago many of the central features of the clinical
electrophysiology of epilepsy and seizures were reasonably clear,
and started to pose the questions brieﬂy outlined in this review. At
that time our understanding of the functional properties of
neurons was accelerating rapidly with the development of
improved recording methods. Since then advances in technology,
ﬁrst in electronics and computers, then in pharmacology andmore
recently in molecular biology, have revolutionised epilepsy
research. The two ﬁelds of cellular and clinical electrophysiology
have converged, in particular through the use of experimental
models of epilepsy, validated where possible by evidence from
clinical recordings or tissue samples. As inmost ﬁelds, themorewe
learn the more we recognise the limits of our knowledge. Exciting
new tools and concepts are coming on-line, for instance in: the
optical control of speciﬁc neurons, the analysis of large datasets of
neuronal recordings, and more reﬁned recordings in vivo both
clinically and experimentally.
The insights gained from studying basic mechanisms of
epilepsy have contributed greatly to progress in brain research,
but what does this progress mean for persons with epilepsy?
Discoveries of the neurotransmitters of the brain led to targeted
drug discovery, which has led to new drugs which have proved
useful, if not always for the predicted reasons. Improvements in
experimental models of epilepsies have helped discover treat-
ments that have some selectivity for seizures generated by
chronic epileptic tissue; they also have led to the recognition
that the development of acquired epilepsies was a speciﬁc
process, epileptogenesis, and that there is an unmet need for
treatments to block or control it. Advances in recording
techniques have led to more speciﬁc electrical signatures for
epileptic foci, particularly fast oscillations, which have improved
the precision of surgery. These are just a few examples of
contributions of basic research on epilepsy over the past 60
years. They have not produced a ‘‘magic bullet’’ to cure epilepsy,
but they have led to many signiﬁcant improvements in
treatment and diagnosis, and I am conﬁdent will continue to
do so for many decades to come.
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